These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Exploration of important sites of antimalarial Endochins for optimum structural modification using group-based QSAR (G-QSAR) modeling. Ojha PK, Roy K. Curr Comput Aided Drug Des; 2013 Sep; 9(3):336-49. PubMed ID: 24010932 [Abstract] [Full Text] [Related]
6. Progress in the Optimization of 4(1H)-Quinolone Derivatives as Antimalarials Targeting the Erythrocytic, the Exoerythrocytic and the Transmitting Stages of the Malaria Parasite. Brockmeyer F, Manetsch R. Chimia (Aarau); 2017 Apr 26; 71(4):213-219. PubMed ID: 28446339 [Abstract] [Full Text] [Related]
7. Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria. Rodrigues T, da Cruz FP, Lafuente-Monasterio MJ, Gonçalves D, Ressurreição AS, Sitoe AR, Bronze MR, Gut J, Schneider G, Mota MM, Rosenthal PJ, Prudêncio M, Gamo FJ, Lopes F, Moreira R. J Med Chem; 2013 Jun 13; 56(11):4811-5. PubMed ID: 23701465 [Abstract] [Full Text] [Related]
8. Aug-MIA-QSAR based strategy in bioactivity prediction of a series of flavonoid derivatives as HIV-1 inhibitors. Muthukumaran P, Rajiniraja M. J Theor Biol; 2019 May 21; 469():18-24. PubMed ID: 30826336 [Abstract] [Full Text] [Related]
10. Introducing new dimensions in MIA-QSAR: a case for chemokine receptor inhibitors. Nunes CA, Freitas MP. Eur J Med Chem; 2013 Apr 21; 62():297-300. PubMed ID: 23357311 [Abstract] [Full Text] [Related]
12. Qsar study of some substituted 4-quinolinyl and 9-acridinyl hydrazones as antimalarial agents. Sahu NK, Sharma M, Mourya V, Kohli DV. Acta Pol Pharm; 2012 Apr 21; 69(6):1153-65. PubMed ID: 23285677 [Abstract] [Full Text] [Related]
13. Ligand based validated comparative chemometric modeling and pharmacophore mapping of aurone derivatives as antimalarial agents. Adhikari N, Halder AK, Mondal C, Jha T. Curr Comput Aided Drug Des; 2013 Sep 21; 9(3):417-32. PubMed ID: 24010937 [Abstract] [Full Text] [Related]
14. Classification models for neocryptolepine derivatives as inhibitors of the β-haematin formation. Dejaegher B, Dhooghe L, Goodarzi M, Apers S, Pieters L, Vander Heyden Y. Anal Chim Acta; 2011 Oct 31; 705(1-2):98-110. PubMed ID: 21962353 [Abstract] [Full Text] [Related]
16. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps. Marrero-Ponce Y, Iyarreta-Veitía M, Montero-Torres A, Romero-Zaldivar C, Brandt CA, Avila PE, Kirchgatter K, Machado Y. J Chem Inf Model; 2005 Oct 31; 45(4):1082-100. PubMed ID: 16045304 [Abstract] [Full Text] [Related]
17. 4(1H)-pyridone and 4(1H)-quinolone derivatives as antimalarials with erythrocytic, exoerythrocytic, and transmission blocking activities. Monastyrskyi A, Kyle DE, Manetsch R. Curr Top Med Chem; 2014 Oct 31; 14(14):1693-705. PubMed ID: 25116582 [Abstract] [Full Text] [Related]
18. Classification SAR modeling of diverse quinolone compounds for antimalarial potency against Plasmodium falciparum. Aher RB, Roy K. Comb Chem High Throughput Screen; 2014 Oct 31; 17(5):396-406. PubMed ID: 24372050 [Abstract] [Full Text] [Related]
19. MIA-QSAR coupled to principal component analysis-adaptive neuro-fuzzy inference systems (PCA-ANFIS) for the modeling of the anti-HIV reverse transcriptase activities of TIBO derivatives. Goodarzi M, Freitas MP. Eur J Med Chem; 2010 Apr 31; 45(4):1352-8. PubMed ID: 20060625 [Abstract] [Full Text] [Related]
20. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum. Qidwai T, Yadav DK, Khan F, Dhawan S, Bhakuni RS. Curr Pharm Des; 2012 Apr 31; 18(37):6133-54. PubMed ID: 22670592 [Abstract] [Full Text] [Related] Page: [Next] [New Search]